Advertisement
Feedback from a high-profile messenger can reduce antibiotic prescribing on a national scale

Feedback From High-Profile Messenger Can Cut Antibiotic Rx

0
Reduction in antibiotic prescribing after receiving letter from England's Chief Medical Officer
Just over half of kidney stone patients are adherent to preventive pharmacological therapy

Only Half of Kidney Stone Patients Compliant With Tx

0
Compliant patients have fewer ER visits, hospitalizations, stone disease surgeries
Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy.

FDA Approves Briviact for Partial Onset Seizures

0
Drug sanctioned for epilepsy patients aged 16 and older
For adults with diabetes

Calcium Channel Blockers Lower Fasting Glucose in Diabetes

0
CCB, especially verapamil, use linked to lower fasting blood glucose levels in adults with diabetes
Antibiotic-associated encephalopathy can be classified into three unique clinical phenotypes

Three Classes of Antibiotic-Associated Encephalopathy ID’d

0
Three unique clinical phenotypes correlate with underlying pathophysiologic mechanisms
For patients with hyperhidrosis

Botulinum Toxin Ups Physical, Mental Health in Hyperhidrosis

0
Reductions in sweat-related health problems, anxiety and depression, symptom severity
Sugammadex at a dose of 4 mg/kg−1 of ideal body weight allows for shorter reversal of deep neuromuscular blockade in morbidly obese patients

High-Dose Sugammadex Speeds Reversal of Neuromuscular Block

0
Shorter recovery time from deep neuromuscular blockade with 4 mg/kg−1 of ideal body weight
Some women aged 40 to 49 years with estrogen receptor-positive breast cancer who undergo chemotherapy-induced amenorrhea regain ovarian function with letrozole

Letrozole Tied to Ovarian Function Recovery in Chemo

0
Findings in women aged 40 to 49 years with estrogen receptor-positive breast cancer
Participants who were taught intensive therapy for type 1 diabetes during the Diabetes Control and Complications Trial experienced clinically beneficial effects on cardiovascular outcomes at 30 years of follow-up

Intensive Diabetes Therapy Cuts CVD Incidence by 30 Percent

0
At 30 years, benefits persist for patients with T1DM in the Diabetes Control and Complications Trial
Testosterone treatment may offer moderate benefit in improving sexual function in older men

Testosterone Therapy Offers Modest Benefits for Older Men

0
Larger studies and long-term follow-up needed to determine possible risks of treatment